Loading…
Loading…
Dr. Sachita Baniya (NMC 20158) is a Consultant Haemato-Oncologist and Clinical Hematologist practising in Nepal. She completed her MBBS at Kumudini Women's Medical College and FCPS in Clinical Haematology, followed by clinical residency at Civil Service Hospital, Kathmandu. With 8+ years of clinical experience and more than 1,000 bone marrow procedures, she evaluates and manages leukemia, lymphoma, multiple myeloma and complex haematological malignancies. Her clinical work includes autologous, allogeneic and haplo-identical bone marrow transplantation, CAR-T cell therapy, advanced molecular testing and flow cytometry. She consults at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, and is affiliated with Kathmandu Cancer Center (KCC) Nepal, Civil Service Hospital, Kathmandu, and Advanced Care Hospital. Her approach emphasises precise diagnosis, clear discussion of treatment options, careful monitoring, and continuity of care for patients and families living with blood cancers and complex blood disorders.
Conditions evaluated
Each guide below is medically reviewed by Dr. Sachita Baniya (NMC 20158).
Services
Haematology Consultation
Specialist assessment for abnormal blood counts, anaemia, low platelets, bleeding, clotting and suspected blood disorders.
Haemato-Oncology Consultation
Consultation for suspected or confirmed blood cancers — leukemia, lymphoma, myeloma and related disorders.
Leukemia Treatment
Diagnosis, risk stratification and treatment planning for acute and chronic leukemias.
Lymphoma Treatment
Diagnosis, staging and treatment planning for Hodgkin and non-Hodgkin lymphomas.
Multiple Myeloma Treatment
Diagnosis and treatment of multiple myeloma, MGUS, smouldering myeloma and AL amyloidosis.
Myelodysplastic Syndrome Treatment
Risk-adapted care for myelodysplastic syndromes and unexplained cytopenias.
Myeloproliferative Neoplasm Treatment
Care for polycythaemia vera, essential thrombocythaemia and primary myelofibrosis.
Bone Marrow Transplant
Autologous, allogeneic and haplo-identical transplant assessment and coordination.
Autologous Bone Marrow Transplant
High-dose therapy with the patient's own stem cells for myeloma and selected lymphomas.
Allogeneic Bone Marrow Transplant
Donor stem cell transplant for selected high-risk blood cancers and marrow failure.
Haplo-Identical Bone Marrow Transplant
Half-matched family donor transplant when a fully matched donor is unavailable.
CAR-T Cell Therapy
Eligibility assessment, referral coordination and follow-up for CAR-T cell therapy.
Bone Marrow Aspiration & Biopsy
Diagnostic bone marrow sampling for cytopenias, suspected blood cancer and treatment monitoring.
Flow Cytometry Evaluation
Immunophenotyping for leukemia, lymphoma, plasma cell disorders and cytopenias.
Molecular Testing in Haematology
Cytogenetics, FISH, PCR and next-generation sequencing for blood cancers.
Anaemia Evaluation
Structured investigation of low haemoglobin — iron deficiency, haemolysis and marrow causes.
Thrombocytopenia Evaluation
Assessment of low platelets including ITP, TTP, drug causes and marrow disorders.
Bleeding Disorder Evaluation
Diagnosis and management of haemophilia, von Willebrand disease and inherited bleeding.
Thrombosis & Anticoagulation
Assessment and management of venous thromboembolism and cancer-associated thrombosis.
Transfusion Support
Red cell and platelet transfusion support for haematological disease and treatment.
Chemotherapy Supportive Care
Infection prevention, transfusion, nausea control and monitoring during blood cancer treatment.
Neutropenia Evaluation
Investigation and management of low white cell counts and recurrent infection.
Graft-Versus-Host Disease Management
Recognition and management of acute and chronic GVHD after allogeneic transplant.
Blood Cancer Survivorship Care
Long-term follow-up after blood cancer treatment and transplantation.
Haematology Second Opinion
Independent review of blood cancer diagnosis, pathology and treatment plans.
Benign Haematology Evaluation
Care for anaemia, cytopenias, bleeding and clotting disorders, thalassaemia and sickle cell disease.
Learn
Popular pages
Frequently asked questions
Reviewed by Dr. Sachita Baniya (NMC 20158).
An initial consultation with Dr. Sachita Baniya (NMC 20158) reviews the symptom timeline, full blood count history, prior bone marrow, flow cytometry, cytogenetic and molecular reports, medications and family history, followed by a focused examination. Additional testing is recommended only when the result will change diagnosis, treatment or monitoring. Bring all blood reports with dates and any prior investigations.
Dr. Sachita Baniya has performed more than 1,000 bone marrow procedures. A biopsy is considered when blood counts, morphology or flow cytometry suggest a marrow disorder — suspected leukemia, lymphoma, myeloma, MDS or marrow failure — or when results are needed for risk stratification and transplant planning. The procedure, risks and alternatives are explained before it is scheduled.
Dr. Sachita Baniya consults at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, and is affiliated with Kathmandu Cancer Center (KCC) Nepal for haemato-oncology, bone marrow transplant and CAR-T services; Civil Service Hospital, Kathmandu for clinical haematology and bone marrow procedures; and Advanced Care Hospital for haematology and haemato-oncology consultation. Appointments are arranged at the Durbar Marg clinic or through the respective hospital or cancer centre.
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.